Dr. Ali Shabahang Saber Tehrani, MD

Dr. Saber Tehrani practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Saber Tehrani's NPI, 1619319472, was assigned on July 22, 2013. Dr. Saber Tehrani holds Maryland license D0085132.

Dr. Saber Tehrani's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Saber Tehrani's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Saber Tehrani is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Saber Tehrani to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saber Tehrani practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Saber Tehrani's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Saber Tehrani's licenses on file in 2 states: Maryland and Illinois.

CMS data shows 147 Medicare services from Dr. Saber Tehrani across 3 procedure codes in 2024, for 38 Medicare patients. Medicare paid $10,979 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 38 Medicare patients who saw Dr. Saber Tehrani in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saber Tehrani's median patient age at 75, with 38% women.

In 2024, Dr. Saber Tehrani wrote 16 Medicare Part D claims. 69% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $1,134 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Saber Tehrani for performance year 2024, reported as part of a group.

Dmand AI links 25 papers to Dr. Saber Tehrani, published from 2013 to 2024. 2024 was the busiest year, with 4. The most frequent topics are Stroke, Vertigo and Dizziness. Dr. Saber Tehrani has published most often in Diagnosis (Berl). Dr. Saber Tehrani's most frequent co-authors are David Edward Newman-Toker, MD, Jorge C. Kattah and Daniel R. Gold, MD.